Direct-to-Consumer Cancer Risk Tests: Are They Worth the Risk?
Direct-to-Consumer Genetic Tests: A Growing Concern A recent editorial published in Oncotarget on December 24, 2024, raises serious concerns about the risks associated with readily available genetic tests for cancer predisposition. the article, penned by Dr. Wafik S. El-Deiry, Editor-in-Chief of Oncotarget, and Dr. Eli Y. Adashi of Brown University, focuses on the “Invitae … Read more